Page 1 | Search Results | Molecular Cancer Therapeutics | American Association for Cancer Research

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Functional Genomic Screen in Mesothelioma Reveals that Loss of Function of BRCA1-Associated Protein 1 Induces Chemoresistance to Ribonucleotide Reductase Inhibition

Agata Okonska, Saskja Bühler, Vasundhara Rao, Manuel Ronner, Maxime Blijlevens, Ida H. van der Meulen-Muileman, Renee X. de Menezes, Martin Wipplinger, Kathrin Oehl, Egbert F. Smit, Walter Weder, Rolf A. Stahel, Lorenza Penengo, Victor W. van Beusechem, Emanuela Felley-Bosco

Mol Cancer Ther (2020) 19 (2): 552–563.

https://doi.org/10.1158/1535-7163.MCT-19-0356

Published: 06 February 2020

View article titled, Functional Genomic Screen in Mesothelioma Reveals that Loss of Function of BRCA1-Associated Protein 1 Induces Chemoresistance to Ribonucleotide Reductase Inhibition

Includes: Supplementary data

Journal Articles

The FA/BRCA Pathway Identified as the Major Predictor of Cisplatin Response in Head and Neck Cancer by Functional Genomics

Sanne R. Martens-de Kemp, Arjen Brink, Ida H. van der Meulen, Renée X. de Menezes, Dennis E. te Beest, C. René Leemans, Victor W. van Beusechem, Boudewijn J.M. Braakhuis, Ruud H. Brakenhoff

Mol Cancer Ther (2017) 16 (3): 540–550.

https://doi.org/10.1158/1535-7163.MCT-16-0457

Published: 02 March 2017

View article titled, The FA/BRCA Pathway Identified as the Major Predictor of Cisplatin Response in Head and Neck Cancer by Functional Genomics

Includes: Supplementary data

Journal Articles

Genome-wide siRNA Screen Identifies the Radiosensitizing Effect of Downregulation of MASTL and FOXM1 in NSCLC

Remco Nagel, Marijke Stigter-van Walsum, Marijke Buijze, Jaap van den Berg, Ida H. van der Meulen, Jasmina Hodzic, Sander R. Piersma, Thang V. Pham, Connie R. Jiménez, Victor W. van Beusechem, Ruud H. Brakenhoff

Mol Cancer Ther (2015) 14 (6): 1434–1444.

https://doi.org/10.1158/1535-7163.MCT-14-0846

Published: 04 June 2015

View article titled, Genome-wide siRNA Screen Identifies the Radiosensitizing Effect of Downregulation of MASTL and FOXM1 in NSCLC

Includes: Supplementary data

Journal Articles

Enhanced tumor cell kill by combined treatment with a small-molecule antagonist of mouse double minute 2 and adenoviruses encoding p53

Harm C.A. Graat, Jan E. Carette, Frederik H.E. Schagen, Lyubomir T. Vassilev, Winald R. Gerritsen, Gertjan J.L. Kaspers, Paul I.J.M. Wuisman, Victor W. van Beusechem

Mol Cancer Ther (2007) 6 (5): 1552–1561.

https://doi.org/10.1158/1535-7163.MCT-06-0631

Published: 18 May 2007

View article titled, Enhanced tumor cell kill by combined treatment with a small-molecule antagonist of mouse double minute 2 and adenoviruses encoding p53

Journal Articles

Conditionally replicative adenovirus expressing degradation-resistant p53 for enhanced oncolysis of human cancer cells overexpressing murine double minute 2

Victor W. van Beusechem, Petra B. van den Doel, Winald R. Gerritsen

Mol Cancer Ther (2005) 4 (6): 1013–1018.

https://doi.org/10.1158/1535-7163.MCT-05-0010

Published: 14 June 2005

View article titled, Conditionally replicative adenovirus expressing degradation-resistant p53 for enhanced oncolysis of human cancer cells overexpressing murine double minute 2

Journal Articles

Gene-directed Enzyme Prodrug Therapy for Osteosarcoma: Sensitization to CPT-11 in Vitro and in Vivo by Adenoviral Delivery of a Gene Encoding Secreted Carboxylesterase-2

Dinja Oosterhoff, M. Adhiambo Witlox, Victor W. van Beusechem, Hidde J. Haisma, Gerard R. Schaap, Johannes Bras, Frank A. Kruyt, Bonnie Molenaar, Epie Boven, Paul I. J. M. Wuisman, Herbert M. Pinedo, Winald R. Gerritsen

Mol Cancer Ther (2003) 2 (8): 765–771.

Published: 25 August 2003

View article titled, Gene-directed Enzyme Prodrug Therapy for Osteosarcoma: Sensitization to CPT-11 <em>in Vitro</em> and <em>in Vivo</em> by Adenoviral Delivery of a Gene Encoding Secreted Carboxylesterase-2

NARROW

Functional Genomic Screen in Mesothelioma Reveals that Loss of Function of BRCA1-Associated Protein 1 Induces Chemoresistance to Ribonucleotide Reductase Inhibition

The FA/BRCA Pathway Identified as the Major Predictor of Cisplatin Response in Head and Neck Cancer by Functional Genomics

Genome-wide siRNA Screen Identifies the Radiosensitizing Effect of Downregulation of MASTL and FOXM1 in NSCLC

Enhanced tumor cell kill by combined treatment with a small-molecule antagonist of mouse double minute 2 and adenoviruses encoding p53

Conditionally replicative adenovirus expressing degradation-resistant p53 for enhanced oncolysis of human cancer cells overexpressing murine double minute 2

Gene-directed Enzyme Prodrug Therapy for Osteosarcoma: Sensitization to CPT-11 in Vitro and in Vivo by Adenoviral Delivery of a Gene Encoding Secreted Carboxylesterase-2

Email alerts

AACR Journals

Functional Genomic Screen in Mesothelioma Reveals that Loss of Function of BRCA1-Associated Protein 1 Induces Chemoresistance to Ribonucleotide Reductase Inhibition

The FA/BRCA Pathway Identified as the Major Predictor of Cisplatin Response in Head and Neck Cancer by Functional Genomics

Genome-wide siRNA Screen Identifies the Radiosensitizing Effect of Downregulation of MASTL and FOXM1 in NSCLC

Enhanced tumor cell kill by combined treatment with a small-molecule antagonist of mouse double minute 2 and adenoviruses encoding p53

Conditionally replicative adenovirus expressing degradation-resistant p53 for enhanced oncolysis of human cancer cells overexpressing murine double minute 2

Gene-directed Enzyme Prodrug Therapy for Osteosarcoma: Sensitization to CPT-11 in Vitro and in Vivo by Adenoviral Delivery of a Gene Encoding Secreted Carboxylesterase-2

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only